KPIs & Operating Metrics(New)
Breakdown Of AssetsCost Of Product SalesDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProperty And EquipmentRevenue By Category Contract Revenue From CollaborationsRevenue By Category Contract Revenue From Collaborations AnnualRevenue By Collaborative Partners AnnualRevenue By Major CustomersRevenue By Major Customers %Revenue By Major Customers AnnualRevenue By Major Customers Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Bottles ShippedTotal Bottles Shipped Annual
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rigel Pharmaceuticals (RIGL) Gross Profit: 2009-2024

Historic Gross Profit for Rigel Pharmaceuticals (RIGL) over the last 15 years, with Dec 2024 value amounting to $160.6 million.

  • Rigel Pharmaceuticals' Gross Profit rose 36.86% to $64.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $262.6 million, marking a year-over-year increase of 86.49%. This contributed to the annual value of $160.6 million for FY2024, which is 46.33% up from last year.
  • Rigel Pharmaceuticals' Gross Profit amounted to $160.6 million in FY2024, which was up 46.33% from $109.8 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Gross Profit registered a high of $160.6 million during FY2024, and its lowest value of $107.7 million during FY2020.
  • Over the past 3 years, Rigel Pharmaceuticals' median Gross Profit value was $118.5 million (recorded in 2022), while the average stood at $129.6 million.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 84.52% in 2020, then fell by 20.02% in 2022.
  • Rigel Pharmaceuticals' Gross Profit (Yearly) stood at $107.7 million in 2020, then skyrocketed by 37.53% to $148.2 million in 2021, then dropped by 20.02% to $118.5 million in 2022, then fell by 7.36% to $109.8 million in 2023, then skyrocketed by 46.33% to $160.6 million in 2024.